经心尖TAVI中经心尖心外膜临时起搏导线的安全性与疗效
该单中心回顾性研究纳入2018年12月至2024年8月接受经心尖TAVI的399例患者,其中298例使用经心尖心外膜临时起搏导线,101例使用经静脉导线。两组均未出现与临时起搏相关的心脏压塞、瓣膜移位或死亡。研究提示经心尖心外膜临时起搏是经心尖TAVI中安全有效的替代方案。
要点
- 经心尖心外膜临时起搏在TAVI中未出现心脏压塞、瓣膜移位或死亡。
- 经心尖组导线接触不良发生率低于经静脉组(0.3% vs 3.0%,p=0.05)。
- 两组术后永久起搏器植入率相近(4.0% vs 3.0%,p=0.86)。
核心结论
- 经心尖心外膜临时起搏是经心尖TAVI中安全有效的替代方案,并发症发生率与经静脉途径相当,并可能具有技术优势。
研究设计与样本
- 单中心回顾性研究,纳入2018年12月至2024年8月接受经心尖TAVI的399例患者。
- 298例使用经心尖心外膜临时起搏导线,101例使用经静脉临时起搏导线。
主要发现
- 两组均未观察到与临时起搏相关的心脏压塞、瓣膜移位或死亡。
- 导线接触不良:经心尖组1例(0.3%),经静脉组3例(3.0%),p=0.05。
- 术后需植入永久起搏器:经心尖组12例(4.0%),经静脉组3例(3.0%),p=0.86。
关键数值与推荐
- 主要结局为与起搏相关的心脏压塞、瓣膜移位和死亡。
- 次要结局包括围术期并发症、永久起搏器植入及术后不良事件。
临床怎么用
- 在经心尖TAVI患者中,经心尖心外膜临时起搏可作为经静脉临时起搏的替代选择。
局限性
- 研究为单中心回顾性设计。
- 需要随机研究验证上述发现并探索长期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective This study aimed to evaluate the safety and efficacy of transapical epicardial temporary pacemaker lead implantation compared with the conventional transvenous approach in patients undergoing transapical transcatheter aortic valve implantation (TAVI). Methods In this single-centre retrospective study, 399 patients who underwent transapical TAVI between December 2018 and August 2024 were included. Of these, 298 received transapical epicardial temporary pacing leads and 101 received transvenous leads. Primary outcomes included pacemaker-related cardiac tamponade, valve displacement and mortality. Secondary outcomes encompassed perioperative complications, permanent pacemaker implantation and postoperative adverse events. Results No cases of cardiac tamponade, valve displacement or mortality related to temporary pacing were observed in either group. Poor lead contact occurred in one patient (0.3%) in the transapical group versus three patients (3.0%) in the transvenous group (p=0.05). Postoperative permanent pacemaker implantation was required in 12 transapical patients (4.0%) and three transvenous patients (3.0%, p=0.86). Conclusion Transapical epicardial temporary pacing is a safe and effective alternative to transvenous pacing during transapical TAVI, with comparable complication rates and potential technical benefits. Further randomised studies are warranted to validate these findings and explore long-term outcomes.
引用
- Open Heart:Transapical epicardial temporary pacemaker lead implantation in patients with transapical TAVI
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。